NL7500364A - Werkwijze om 1,4-benzodiazepinen te bereiden. - Google Patents

Werkwijze om 1,4-benzodiazepinen te bereiden.

Info

Publication number
NL7500364A
NL7500364A NL7500364A NL7500364A NL7500364A NL 7500364 A NL7500364 A NL 7500364A NL 7500364 A NL7500364 A NL 7500364A NL 7500364 A NL7500364 A NL 7500364A NL 7500364 A NL7500364 A NL 7500364A
Authority
NL
Netherlands
Prior art keywords
substd
alkyl
psychotherapeutic
ketimines
benzodiazepin
Prior art date
Application number
NL7500364A
Other languages
English (en)
Other versions
NL155828B (nl
Original Assignee
Clin Midy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clin Midy filed Critical Clin Midy
Publication of NL7500364A publication Critical patent/NL7500364A/nl
Publication of NL155828B publication Critical patent/NL155828B/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Devices For Post-Treatments, Processing, Supply, Discharge, And Other Processes (AREA)
  • Perforating, Stamping-Out Or Severing By Means Other Than Cutting (AREA)
NL7500364.A 1964-06-15 1975-01-13 Werkwijze om 1,4-benzodiazepinen te bereiden, alsmede werkwijze om farmaceutische preparaten te bereiden met psychofarmacologische werking en aldus verkregen voorwerpen. NL155828B (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR978360A FR1497456A (fr) 1964-06-15 1964-06-15 Ortho-amino aryl cétimines, composés hétérocycliques qui s'y rattachent et prépaation de ces divers corps
FR12886A FR91403E (fr) 1964-06-15 1965-04-12 Ortho-amino aryl cétimines, composés hétérocycliques qui s'y rattachent et préparation de ces divers corps
NL6507637.A NL155545B (nl) 1964-06-15 1965-06-15 Werkwijze om azomethinen te breiden, alsmede werkwijze om farmaceutische preparaten te bereiden, alsmede aldus verkregen voorwerpen.

Publications (2)

Publication Number Publication Date
NL7500364A true NL7500364A (nl) 1975-04-29
NL155828B NL155828B (nl) 1978-02-15

Family

ID=26163072

Family Applications (2)

Application Number Title Priority Date Filing Date
NL6507637.A NL155545B (nl) 1964-06-15 1965-06-15 Werkwijze om azomethinen te breiden, alsmede werkwijze om farmaceutische preparaten te bereiden, alsmede aldus verkregen voorwerpen.
NL7500364.A NL155828B (nl) 1964-06-15 1975-01-13 Werkwijze om 1,4-benzodiazepinen te bereiden, alsmede werkwijze om farmaceutische preparaten te bereiden met psychofarmacologische werking en aldus verkregen voorwerpen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL6507637.A NL155545B (nl) 1964-06-15 1965-06-15 Werkwijze om azomethinen te breiden, alsmede werkwijze om farmaceutische preparaten te bereiden, alsmede aldus verkregen voorwerpen.

Country Status (17)

Country Link
US (1) US3516988A (nl)
AT (2) AT284084B (nl)
BE (1) BE665401A (nl)
BR (1) BR6570433D0 (nl)
CA (2) CA958707A (nl)
CH (2) CH485741A (nl)
DE (2) DE1795832C3 (nl)
DK (3) DK138493B (nl)
FI (2) FI47986C (nl)
FR (3) FR1497456A (nl)
GB (3) GB1117062A (nl)
IL (2) IL23712A (nl)
MY (3) MY7100181A (nl)
NL (2) NL155545B (nl)
NO (1) NO120115B (nl)
SE (2) SE336341B (nl)
YU (3) YU100565A (nl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2008612A1 (de) * 1969-03-13 1970-10-01 F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) Benzodiazepin-Derivate
FR2012061A1 (en) * 1969-06-30 1970-03-13 Sandoz Sa Quinazolinone derivs - with antiphlogistic props
GB1538164A (en) * 1976-05-05 1979-01-10 Clin Midy Benzodiazepine derivatives
FR2470116A1 (fr) * 1979-11-27 1981-05-29 Synthelabo Derives benzylideniques, leur preparation et leur application en therapeutique
JPS6019753A (ja) * 1983-07-13 1985-01-31 Shionogi & Co Ltd オルト−(モノ置換アミノ)フエニルイミン類およびその製造法
JPS6038380A (ja) * 1983-08-11 1985-02-27 Shionogi & Co Ltd 1−ピペリジニル−1,4−ベンゾジアゼピン類の改良合成法
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
EP1143946B1 (en) * 1999-04-30 2004-01-28 The Regents Of The University Of Michigan Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
IL159105A0 (en) 2001-06-07 2004-05-12 Neuro3D Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
CA3099791A1 (en) 2018-05-29 2019-12-05 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
US12077512B2 (en) 2019-03-25 2024-09-03 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3410844A (en) * 1966-03-14 1968-11-12 American Home Prod 2, 3, 4, 5-tetrahydro-2-oxo-1h-1, 4-benzodiazepine-3-carboxylic acid, esters and related compounds

Also Published As

Publication number Publication date
DE1518764C3 (de) 1980-02-21
DE1795445B2 (de) 1976-02-26
DK138493C (nl) 1979-02-26
DK129126B (da) 1974-08-26
NL155828B (nl) 1978-02-15
FR1497456A (fr) 1967-10-13
BE665401A (nl) 1965-12-14
US3516988A (en) 1970-06-23
FI47986C (fi) 1974-05-10
DE1795445A1 (de) 1973-01-11
FR4206M (nl) 1966-07-11
YU35570B (en) 1981-04-30
YU45468A (en) 1980-10-31
DE1795832B2 (de) 1980-07-17
IL32140A (en) 1969-07-30
DE1518764B2 (de) 1979-06-21
MY7100180A (en) 1971-12-31
GB1117063A (en) 1968-06-12
IL23712A (en) 1969-07-30
CA958708A (en) 1974-12-03
CH479552A (fr) 1969-10-15
GB1117062A (en) 1968-06-12
BR6570433D0 (pt) 1973-08-14
SE336341B (nl) 1971-07-05
YU100565A (en) 1975-08-31
AT284084B (de) 1970-08-25
FI47986B (nl) 1974-01-31
MY7100181A (en) 1971-12-31
NL155545B (nl) 1978-01-16
CA958707A (en) 1974-12-03
SE386891B (sv) 1976-08-23
NL6507637A (nl) 1965-12-16
FI51586C (fi) 1977-02-10
MY7100179A (en) 1971-12-31
CA958708B (en)
DE1518764A1 (de) 1971-11-04
NO120115B (nl) 1970-08-31
CH485741A (fr) 1970-02-15
FI51586B (nl) 1976-11-01
DK129126C (nl) 1975-01-06
DK125856B (da) 1973-05-14
DE1795832A1 (de) 1976-04-22
YU32996B (en) 1976-03-31
GB1117061A (en) 1968-06-12
AT268285B (de) 1969-02-10
DE1795832C3 (de) 1981-07-02
DK138493B (da) 1978-09-18
FR91403E (fr) 1968-06-07
CA958707B (en)

Similar Documents

Publication Publication Date Title
NL7500364A (nl) Werkwijze om 1,4-benzodiazepinen te bereiden.
ES423479A1 (es) Procedimiento para preparar n-metil-carbamidoximas n-sulfe-niladas.
NL7117845A (en) Vasodilatory and hypotensive 2-substd adenosine prepn - by reaction of ammonia and 2,6- disubstd nebularins
FR2024548A1 (en) Ortho-substd phenethylamines and medicaments
FR2047462A5 (en) 1-hydroxy-benzimidazole-z-carbpxy acid - amides and esters
SE7513882L (sv) Nya orgniska foreningar
GB1180745A (en) Penicillins
FR2053742A5 (en) Prepn of 3-acyl-1,2,4-oxadiazoles useful in syn - of medicaments, in plant protection and as inter
GB1077465A (en) Mercapto-phenoxymethyl-penicillins and a process for their manufacture
FR2152374A1 (en) Ellipticin and analogues - by an industrial scale process
FR2068454A1 (en) Alpha-amino - penicillins
NL7210549A (en) 4-Alkoxy or hydroxy-5-phenyl-3-thienylalkano-ic acids - antiphlogistics
FR2058611A5 (en) N-(2-benzimidazolyl) carbamic acid derivs - prepn
GB889066A (en) Improvements in or relating to substances produced from penicillin-producing moulds
FR2014689A1 (en) Enzymatic prepn of semi-synthetic penicillins
FR2100909A1 (fr) Amides de l'acide indazole-3-carboxylique et procedes de preparation
FR2181506A1 (en) Penicillin amides - with improved resistance to penicillinase
GB1088880A (en) ª‡-cycloalkyleneimino-substituted esters
FR2089394A5 (en) N-(trihalomethyl thio)-n-methyl-carbamid-oxi -
FR2101045A1 (en) Omega-dialkylamino-1-(2,4,6-trialkoxy phenyl) alkan-1-ones - with vasodilator and spasmolytic activity
ES329306A1 (es) Un metodo para producir un compuesto util como agente antiinflamatorio y uricosurico.
FR2059484A1 (en) Pharmaceutical intermediate 3-acylamine - pyrrolidinedione (2 4) compounds
GB906383A (en) Improvements in or relating to penicillins
FR2240730A1 (en) Hypotensive and psychopharmacologic indoles - with 3-hydrocarbyl carbonyl or 3-hydrocarbyloxy carbonyl substs.
FR2047868A1 (en) Thiazolidine-2,4-dicarboxylic acids

Legal Events

Date Code Title Description
SNR Assignments of patents or rights arising from examined patent applications

Owner name: SANOFI SOCIETE ANONYME

NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: CM INDUSTRIES

V4 Discontinued because of reaching the maximum lifetime of a patent